Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity

Steven J. Kridel(Atrium Health Wake Forest Baptist), Jeffrey W. Smith(Mirati Therapeutics (United States))
Cancer Research
March 15, 2004
Cited by 597


Related Papers